| Dr Richard Harold Huggins, MD | |
|
3031 W Grand Blvd, Suite 800, Dermatology, Detroit, MI 48202-3046 | |
| (313) 916-2151 | |
| Not Available |
| Full Name | Dr Richard Harold Huggins |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 18 Years |
| Location | 3031 W Grand Blvd, Detroit, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619136934 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 4301092993 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Henry Ford Hospital | Detroit, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Henry Ford Medical Group | 0547178311 | 2095 |
News Archive
March is National Autoimmune Disease Awareness Month 2013. To mark the annual event, the American Autoimmune Related Diseases Association Inc. (AARDA) is encouraging the national and local media around the country to report stories on autoimmune diseases (AD) and autoimmunity as a category of disease.
An inflammatory protein that triggers a pregnant mouse's immune response to an infection or other disease appears to cause brain injury in her fetus, but not the premature birth that was long believed to be linked with such neurologic damage in both rodents and humans, new Johns Hopkins-led research suggests.
ARKRAY, Inc., the world's 5th largest manufacturer of diabetes self-monitoring systems, today announced that it has received 510(k) clearance from the US Food and Drug Administration for its new GLUCOCARD Vital blood glucose monitoring system.
Affymax, Inc. today announced that it has instituted a quiet period to curtail discussions with the investor community and the media in connection with the analysis of Phase 3 results for the investigational drug, Hematide, in four clinical trials (PEARL 1, PEARL 2, EMERALD 1 and EMERALD 2) which evaluated Hematide for the treatment of anemia in chronic renal failure patients.
Rethink Breast Cancer is turning out the lights and putting boobies on the big screen at the 2009 Breast Fest Film Festival. After a successful inaugural year, the world's first breast cancer film festival is back in Toronto this weekend with a new selection of inspiring films that span the emotional spectrum of the breast cancer journey. As part of Breast Fest's expanded three-day program, Rethink will unveil more panel discussions and workshops to inspire dialogue, facilitate learning and foster community.
› Verified 6 days ago
| Entity Name | Henry Ford Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730252339 PECOS PAC ID: 0547178311 Enrollment ID: O20031111000124 |
News Archive
March is National Autoimmune Disease Awareness Month 2013. To mark the annual event, the American Autoimmune Related Diseases Association Inc. (AARDA) is encouraging the national and local media around the country to report stories on autoimmune diseases (AD) and autoimmunity as a category of disease.
An inflammatory protein that triggers a pregnant mouse's immune response to an infection or other disease appears to cause brain injury in her fetus, but not the premature birth that was long believed to be linked with such neurologic damage in both rodents and humans, new Johns Hopkins-led research suggests.
ARKRAY, Inc., the world's 5th largest manufacturer of diabetes self-monitoring systems, today announced that it has received 510(k) clearance from the US Food and Drug Administration for its new GLUCOCARD Vital blood glucose monitoring system.
Affymax, Inc. today announced that it has instituted a quiet period to curtail discussions with the investor community and the media in connection with the analysis of Phase 3 results for the investigational drug, Hematide, in four clinical trials (PEARL 1, PEARL 2, EMERALD 1 and EMERALD 2) which evaluated Hematide for the treatment of anemia in chronic renal failure patients.
Rethink Breast Cancer is turning out the lights and putting boobies on the big screen at the 2009 Breast Fest Film Festival. After a successful inaugural year, the world's first breast cancer film festival is back in Toronto this weekend with a new selection of inspiring films that span the emotional spectrum of the breast cancer journey. As part of Breast Fest's expanded three-day program, Rethink will unveil more panel discussions and workshops to inspire dialogue, facilitate learning and foster community.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard Harold Huggins, MD 3031 W Grand Blvd, Suite 800, Detroit, MI 48202-3046 Ph: (313) 916-2151 | Dr Richard Harold Huggins, MD 3031 W Grand Blvd, Suite 800, Dermatology, Detroit, MI 48202-3046 Ph: (313) 916-2151 |
News Archive
March is National Autoimmune Disease Awareness Month 2013. To mark the annual event, the American Autoimmune Related Diseases Association Inc. (AARDA) is encouraging the national and local media around the country to report stories on autoimmune diseases (AD) and autoimmunity as a category of disease.
An inflammatory protein that triggers a pregnant mouse's immune response to an infection or other disease appears to cause brain injury in her fetus, but not the premature birth that was long believed to be linked with such neurologic damage in both rodents and humans, new Johns Hopkins-led research suggests.
ARKRAY, Inc., the world's 5th largest manufacturer of diabetes self-monitoring systems, today announced that it has received 510(k) clearance from the US Food and Drug Administration for its new GLUCOCARD Vital blood glucose monitoring system.
Affymax, Inc. today announced that it has instituted a quiet period to curtail discussions with the investor community and the media in connection with the analysis of Phase 3 results for the investigational drug, Hematide, in four clinical trials (PEARL 1, PEARL 2, EMERALD 1 and EMERALD 2) which evaluated Hematide for the treatment of anemia in chronic renal failure patients.
Rethink Breast Cancer is turning out the lights and putting boobies on the big screen at the 2009 Breast Fest Film Festival. After a successful inaugural year, the world's first breast cancer film festival is back in Toronto this weekend with a new selection of inspiring films that span the emotional spectrum of the breast cancer journey. As part of Breast Fest's expanded three-day program, Rethink will unveil more panel discussions and workshops to inspire dialogue, facilitate learning and foster community.
› Verified 6 days ago
Dr. Laurie Linden Kohen, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3031 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-2171 | |
James A Brown, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 22151 Moross, Suite 234, Detroit, MI 48236 Phone: 313-885-5110 Fax: 313-885-8755 | |
David M. Ozog, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3031 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-2454 | |
Dr. Emily L. Keimig, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3031 W Grand Blvd, Suite 800, Detroit, MI 48202 Phone: 313-916-2171 | |
Dr. Alison Tisack Boucher, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3031 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-2151 | |
Marsha L. Chaffins, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: Henry Ford Health System, 3031 West Grand Blvd., Detroit, MI 48202 Phone: 313-916-2454 | |
Dr. Snehal R Desai, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3031 W Grand Blvd, Suite 800, Detroit, MI 48202 Phone: 313-916-2171 |